Stable efficacy and safety after switching from intravenous to subcutaneous tocilizumab in a cohort of 200 patients in real life conditions - 29/06/22
Doi : 10.1016/j.jbspin.2022.105347
Guillaume Larid a, b, ⁎ 
, Laurie Joffres a, Emilie Ricard c, Céline Pereira Gillion d, Marion Herbette e, Charlotte Lucas f, Jean Baptiste Cren g, Emmanuelle Bergeal h, Yves Maugars i, Carine Salliot c, Philippe Goupille d, Alain Saraux e, Aleth Perdriger f, Béatrice Bouvard g, Elisabeth Gervais a, b
, Laurie Joffres a, Emilie Ricard c, Céline Pereira Gillion d, Marion Herbette e, Charlotte Lucas f, Jean Baptiste Cren g, Emmanuelle Bergeal h, Yves Maugars i, Carine Salliot c, Philippe Goupille d, Alain Saraux e, Aleth Perdriger f, Béatrice Bouvard g, Elisabeth Gervais a, bSociété de Rhumatologie de l’Ouest and the network VICTOR HUGO
a Rheumatology Unit, Poitiers, University Hospital, 2, rue de la milétrie CS90577, 86021 Poitiers Cedex, France
b LITEC laboratory, EA4331, University of Poitiers, 86000 Poitiers, France
c Rheumatology Unit, Orléans, General Hospital, 14, avenue de l’hôpital CS 86709, 45067 Orléans Cedex 2, France
d Rheumatology Unit, University Hospital, Centre Hospitalier Régional Universitaire de Tours, 37044 Tours cedex 9, France
e Rheumatology Unit, University Hospital, Hôpital de La Cavale Blanche, boulevard Tanguy Prigent Brest, 29200 Brest, France
f Rheumatology Unit, Rennes, University Hospital, 2, rue Henri Le Guilloux, 35033 Rennes cedex 9, France
g Rheumatology Unit, Angers, University Hospital, 4, rue Larrey, 49100 Angers, France
h Medical information Unit, La Rochelle, General Hospital, rue du docteur Schweitzer, 17000 La Rochelle, France
i Rheumatology Unit, Nantes, University Hospital, 1, place Alexis-Ricordeau, 44093 Nantes Cedex 1, France
⁎Corresponding author at: Rheumatology department, CHU Poitiers, 2,rue de la Milétrie CS90577, 86021 Poitiers Cedex, France.Rheumatology department, CHU Poitiers2,rue de la Milétrie CS90577Poitiers Cedex86021France
Keywords : Rheumatoid arthritis, Drug therapy, Antirheumatic agents, Tocilizumab, Drug switch
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2022
Société française de rhumatologie. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 89 - N° 4
Articolo 105347- luglio 2022 Ritorno al numero
Articolo precedente
- Histological and imaging characteristics of acute colchicine myotoxicity
- Baptiste Quéré, Amélie Bourhis, Pascale Marcorelles, Arnaud Uguen, Jean-Baptiste Noury, Zarrin Alavi, Divi Cornec, Dewi Guellec
- G- CSF treatment for refractory digital ulcers in systemic sclerosis
- Shiri Keret, Gleb Slobodin, Abid Awisat, Lisa Kaly, Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Aniela Shouval, Doron Rimar
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?